(Q28574150)

English

Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling

scientific journal article

In more languages

Statements

scholarly article

1 reference

31 January 2017

Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling (English)

1 reference

31 January 2017

phosphorylation

0 references

author name string

Ying-Hsien Huang

1

1 reference

31 January 2017

Jiin-Haur Chuang

2

1 reference

31 January 2017

Ya-Ling Yang

3

1 reference

31 January 2017

Chao-Cheng Huang

4

1 reference

31 January 2017

Chia-Ling Wu

5

1 reference

31 January 2017

Chao-Long Chen

6

1 reference

31 January 2017

publication date

1 October 2009

1 reference

31 January 2017

Laboratory Investigation

1 reference

31 January 2017

89

1 reference

31 January 2017

10

1 reference

31 January 2017

1128–1139

1 reference

31 January 2017

LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2009.82

21 April 2017

Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2009.82

21 April 2017

A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2009.82

21 April 2017

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2009.82

21 April 2017

A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2009.82

21 April 2017

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.2009.82

21 April 2017

Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Bacterial cholangitis in patients with biliary atresia: impact on short-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Liver hepcidin and stainable iron expression in biliary atresia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Altered expression of iron regulatory genes in cirrhotic human livers: clues to the cause of hemosiderosis?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Dysregulation of systemic iron metabolism in alcoholic liver diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

The nexus of iron and inflammation in hepcidin regulation: SMADs, STATs, and ECSIT.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Effect of glucocorticoid pretreatment on oxidative liver injury and survival in jaundiced rats with endotoxin cholangitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Three different hepcidins from tilapia, Oreochromis mossambicus: analysis of their expressions and biological functions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Regulation of hepcidin transcription by interleukin-1 and interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Endothelial cells require STAT3 for protection against endotoxin-induced inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Hereditary hemochromatosis--a new look at an old disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Attenuation of acute and chronic liver injury in rats by iron-deficient diet

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

21 January 2018

Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in bacterial concentration in the liver correlate with that in the hepaticojejunostomy after bile duct reconstruction: implication in the pathogenesis of postoperative cholangitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

7 January 2021

based on heuristic

inferred from DOI database lookup

Conclusive evidence of endotoxaemia in biliary obstruction

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of choice for choledocholithiasis in patients with acute obstructive suppurative cholangitis and liver cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholestatic Interleukin-6–Deficient Mice Succumb to Endotoxin-induced Liver Injury and Pulmonary Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2009.82

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28574150&oldid=2175273641"